Icon’s impressive capabilities have attracted large pharmaceutical clients, including a preferred partnership with Pfizer. Historically, Icon's revenue heavily relied on Pfizer, its largest customer, ...
Icon reported solid fourth-quarter revenue of $1.8 billion and ended the year with total revenue of nearly $5.5 billion, in line with expectations. Icon’s acquisition of PRA Health Sciences, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback